HealthStream (NASDAQ:HSTM) Announces Earnings Results

HealthStream (NASDAQ:HSTM) released its quarterly earnings results on Monday. The technology company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.06, Briefing.com reports. The firm had revenue of $73.10 million during the quarter, compared to analysts’ expectations of $73.53 million. HealthStream had a return on equity of 5.19% and a net margin of 6.26%. HealthStream’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.13 EPS. HealthStream updated its FY 2024 guidance to EPS.

HealthStream Price Performance

Shares of HSTM traded down $1.44 during trading hours on Wednesday, reaching $28.63. 163,778 shares of the company’s stock traded hands, compared to its average volume of 112,590. The firm has a market capitalization of $870.29 million, a price-to-earnings ratio of 49.36, a P/E/G ratio of 4.25 and a beta of 0.36. HealthStream has a twelve month low of $22.84 and a twelve month high of $31.15. The business’s fifty day simple moving average is $28.68 and its two-hundred day simple moving average is $27.88.

HealthStream Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a $0.028 dividend. This represents a $0.11 annualized dividend and a yield of 0.39%. The ex-dividend date is Monday, November 4th. HealthStream’s dividend payout ratio is presently 18.97%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Canaccord Genuity Group increased their target price on HealthStream from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Wednesday. Craig Hallum raised HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. StockNews.com lowered HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Finally, Barclays upped their price target on HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.50.

Insider Activity

In other news, SVP Kevin P. O’hara sold 3,000 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares of the company’s stock, valued at approximately $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, SVP Kevin P. O’hara sold 3,000 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total transaction of $84,090.00. Following the completion of the transaction, the senior vice president now owns 9,527 shares of the company’s stock, valued at $267,041.81. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Tate Deborah Taylor sold 1,400 shares of the firm’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the transaction, the director now directly owns 22,326 shares of the company’s stock, valued at $636,960.78. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 20.60% of the company’s stock.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.